ArticleThe Journal of clinical investigation2025

Reduced EIF6 dosage attenuates TP53 activation in models of Shwachman-Diamond syndrome.

Usua Oyarbide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.